A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Trial Identifier: D8540C00002
Sponsor: MedImmune, LLC
NCTID:: NCT03811652
Start Date: December 2018
Primary Completion Date: December 2019
Study Completion Date: December 2019
Condition: Prostate Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations